A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)
|ClinicalTrials.gov Identifier: NCT02519088|
Recruitment Status : Completed
First Posted : August 10, 2015
Last Update Posted : October 12, 2015
The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany.
A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.
The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||477 participants|
|Official Title:||A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty|
|Study Start Date :||August 2015|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||October 2015|
- Events and circumstances of Homologous Blood Transfusion (erythrocyte concentrate transfusion) [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 10 days ]Multivariate analysis of predictive variables like age, sex, BMI, hip and belly circumference, chronic kidney disease, chronic cardio-vascular disease, chronic inflammatory disease, diabetes mellitus, cancer, ASA Score, cemented, hybrid or not cemented prosthesis, surgery duration, medication and hemoglobin level before surgery
- pPBM Computer Simulation [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 10 days ]Introducing the pPBM App as a safe blood-sparing strategy
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02519088
|Krankenhaus der Barmherzigen Brüder Trier|
|Trier, Rheinland-Pfalz, Germany, 54292|
|Principal Investigator:||Ion-Andrei Popescu, MD||Krankenhaus der Barmherzigen Brüder Trier|